scholarly article | Q13442814 |
P50 | author | Graham Colditz | Q5592728 |
Bernard A. Rosner | Q76570651 | ||
Susan E. Hankinson | Q76570836 | ||
Janet Rich-Edwards | Q87271575 | ||
Stacey Missmer | Q91277908 | ||
Karin B. Michels | Q92307907 | ||
Brittany M Charlton | Q92367994 | ||
Frank E. Speizer | Q28114643 | ||
P2860 | cites work | Progestins and breast cancer | Q56030177 |
Carcinogenicity of combined oestrogen-progestagen contraceptives and menopausal treatment | Q57560086 | ||
Phasic contraceptive pills and functional ovarian cysts | Q68159359 | ||
Functional ovarian cysts and oral contraceptives. Negative association confirmed surgically. A cooperative study | Q68773369 | ||
Breast cancer and combined oral contraceptives: results from a multinational study. The WHO Collaborative Study of Neoplasia and Steroid Contraceptives | Q68926745 | ||
Patterns of oral contraceptive use in the United States | Q69805159 | ||
Test of the National Death Index | Q71344931 | ||
Ovarian function during low-dose oral contraceptive use | Q71732197 | ||
Further analyses of mortality in oral contraceptive users. Royal College of General Practitioners' Oral Contraception Study | Q72464161 | ||
Oral contraceptives and risk of breast cancer in women aged 20-54 years. Netherlands Oral Contraceptives and Breast Cancer Study Group | Q72692127 | ||
Mortality and the pill. Wrong conclusions drawn, again | Q84204046 | ||
Mortality among contraceptive pill users: cohort evidence from Royal College of General Practitioners' Oral Contraception Study | Q24629702 | ||
The Royal College of General Practitioners' Oral Contraception Study: some recent observations | Q28269824 | ||
Breast cancer and hormonal contraceptives: further results. Collaborative Group on Hormonal Factors in Breast Cancer | Q28295346 | ||
A prospective study of oral contraceptive use and risk of breast cancer (Nurses' Health Study, United States) | Q28304748 | ||
Ovarian cancer and oral contraceptives: collaborative reanalysis of data from 45 epidemiological studies including 23,257 women with ovarian cancer and 87,303 controls | Q31147531 | ||
Ischemic stroke risk with oral contraceptives: A meta-analysis | Q33953321 | ||
Factors affecting mortality in a large cohort study with special reference to oral contraceptive use. | Q34130935 | ||
Oral contraceptive use and breast cancer: a prospective study of young women | Q34134707 | ||
Mortality in relation to oral contraceptive use and cigarette smoking | Q34217740 | ||
Maternal deaths averted by contraceptive use: an analysis of 172 countries | Q34287361 | ||
Oral contraceptive use and risk of breast cancer: a meta-analysis of prospective cohort studies | Q34305820 | ||
Oral contraceptive use and mortality during 12 years of follow-up: the Nurses' Health Study | Q34339315 | ||
Oral contraceptives and mood | Q34390323 | ||
Mortality associated with oral contraceptive use: 25 year follow up of cohort of 46 000 women from Royal College of General Practitioners' oral contraception study | Q34486389 | ||
Production and actions of estrogens | Q34513002 | ||
Oral contraceptive use as a risk factor for premenopausal breast cancer: a meta-analysis | Q34573557 | ||
To what extent do oral contraceptives influence mood and affect? | Q34750705 | ||
Risk factors for mortality in the nurses' health study: a competing risks analysis | Q35017437 | ||
Mortality among oral contraceptive users: 20 year follow up of women in a cohort study | Q35719637 | ||
Association of hormonal contraceptive use with reduced levels of depressive symptoms: a national study of sexually active women in the United States | Q37463944 | ||
Oral contraceptives and colorectal cancer risk: a systematic review and meta-analysis | Q37469729 | ||
Hormonal contraception and risk of endometrial cancer: a systematic review | Q37792640 | ||
The state of hormonal contraception today: established and emerging noncontraceptive health benefits | Q37941079 | ||
Reproducibility of oral contraceptive histories and validity of hormone composition reported in a cohort of US women | Q38503066 | ||
Oral contraceptives use and the risk of myocardial infarction: a meta-analysis | Q39130555 | ||
Contraceptive use and associations with intimate partner violence among a population-based sample of New Zealand women | Q39834589 | ||
The Nurses' Health Study | Q40382857 | ||
A randomized, double-blind, placebo-controlled comparison of the impact of low-dose and triphasic oral contraceptives on follicular development | Q41111787 | ||
Oral contraceptive type and functional ovarian cysts | Q41114193 | ||
Oral contraception and health. | Q43136786 | ||
Oral contraceptives in the United States: trends in content and potency | Q45276872 | ||
Hormonal contraception and mental health: results of a population-based study | Q45372447 | ||
Use of contraception in the United States: 1982-2008 | Q46869329 | ||
Use of oral contraceptives and mortality during 14 years' follow-up of Norwegian women | Q46921099 | ||
Test of the National Death Index and Equifax Nationwide Death Search. | Q52363384 | ||
P407 | language of work or name | English | Q1860 |
P304 | page(s) | g6356 | |
P577 | publication date | 2014-10-31 | |
P1433 | published in | The BMJ | Q546003 |
P1476 | title | Oral contraceptive use and mortality after 36 years of follow-up in the Nurses' Health Study: prospective cohort study | |
P478 | volume | 349 |
Q33641708 | A Review of hormone-based therapies to treat adult acne vulgaris in women |
Q91258014 | A prospective clinical cohort study of women at increased risk for endometrial cancer |
Q36991832 | A prospective cohort study of endometriosis and subsequent risk of infertility. |
Q92621113 | A prospective investigation of oral contraceptive use and breast cancer mortality: findings from the Swedish women's lifestyle and health cohort |
Q55713330 | Benefits of reversible contraception. |
Q37704116 | Changing trends in reproductive/lifestyle factors in UK women: descriptive study within the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS) |
Q92127319 | Combined but not single treatment with ethinylestradiol/levonorgestrel and spironolactone reduces plasminogen activator inhibitor-1 in insulin-resistant ovariectomised rats |
Q64098384 | Continuous Use of Combined Hormonal Contraceptive and the Effect on Blood Coagulation Factors in Female Capuchin Monkeys () |
Q64078095 | Epigenome-wide association study for lifetime estrogen exposure identifies an epigenetic signature associated with breast cancer risk |
Q33729336 | Estrogen Effects on the Mammary Gland in Early and Late Life and Breast Cancer Risk |
Q52985664 | Exogenous Hormone Use: Oral Contraceptives, Postmenopausal Hormone Therapy, and Health Outcomes in the Nurses' Health Study. |
Q90497405 | Female reproductive factors and risk of external causes of death among women: The Japan Public Health Center-based Prospective Study (JPHC Study) |
Q92723013 | Hierarchies of evidence applied to lifestyle Medicine (HEALM): introduction of a strength-of-evidence approach based on a methodological systematic review |
Q38562815 | Impact of progesterone on stem/progenitor cells in the human breast |
Q92070408 | Long-acting reversible contraception: A route to reproductive justice or injustice |
Q38579398 | Meta-analysis of oral contraceptive use and risks of all-cause and cause-specific death. |
Q33631557 | Minireview: Progesterone Regulation of Proliferation in the Normal Human Breast and in Breast Cancer: A Tale of Two Scenarios? |
Q100755293 | Oral contraceptive use and risk of suicidal behavior among young women |
Q96961742 | Pille, Depression und Suizid – ein Statement aus kinder- und jugendpsychiatrischer und gynäkologischer Sicht |
Q38619701 | Real-world research and the role of observational data in the field of gynaecology - a practical review |
Q35826696 | Reproductive factors and risk of mortality in the European Prospective Investigation into Cancer and Nutrition; a cohort study |
Search more.